Atlas Trials

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT05836324 · RECRUITING

Trial details

NCT number
NCT05836324
Sponsor
Incyte Corporation
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorsAdvanced Solid TumorsMetastatic Solid Tumors
Start date
2023-07-24
Primary completion
2029-05-03
Enrollment
570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.